Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Unaudited)

v3.23.3
Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current assets    
Cash $ 9,143,619 $ 13,468,026
Non-current assets    
Acquired patents, net 6,294 9,003
Total assets 9,149,913 13,477,029
Current liabilities    
Accounts payable & accrued interest 230,902 220,845
Unreimbursed expenses 66,385 42,060
Total current liabilities 297,287 262,905
Total liabilities 297,287 262,905
Stockholders’ equity    
Common stock, $0.001 par value; 100,000,000 shares authorized; 12,848,165 shares issued and outstanding as of September 30, 2023 and December 31, 2022 12,848 12,848
Additional paid-in capital 56,457,608 54,674,042
Accumulated deficit (47,617,830) (41,472,766)
Total stockholders’ equity 8,852,626 13,214,124
Total liabilities and stockholders’ equity $ 9,149,913 $ 13,477,029